(Q43687351)

25 November 2017

Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy (English)

1 reference

inflammatory bowel diseases

25 November 2017

0 references

1 reference

Fraser JS

1

1 reference

25 November 2017

Muller AF

2

1 reference

25 November 2017

Smith DJ

3

1 reference

25 November 2017

Newman DJ

4

1 reference

25 November 2017

Lamb EJ

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Alimentary Pharmacology & Therapeutics

25 November 2017

1 reference

25 November 2017

15

1 reference

25 November 2017

8

1 reference

25 November 2017

1131-1137

1 reference

What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

25 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Mesalazine induced interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Chronic interstitial nephritis due to 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Mesalazine-associated interstitial nephritis: twice in the same patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Mesalazine-associated interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Microalbuminuria as a predictor of clinical diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

A simple index of Crohn's-disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Colorimetric assays for N-acetyl-beta-D-glucosaminidase and beta-D-galactosidase in human urine using newly-developed omega-nitrostyryl substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Prevention of diabetic renal disease with special reference to microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Tests of renal function in patients with quiescent colitis: effects of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Microalbuminuria in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

Creatinine clearance and glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01041.X

10.1046/J.1365-2036.2001.01041.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference